Cyclobenzaprine is the generic form of Flexeril, a skeletal muscle relaxant prescribed for muscle spasm linked to acute back and neck strain. In 2026 the drug is sold only as a generic in the United States because brand Flexeril was discontinued years ago. The 10 mg tablet is the most common strength, and a 30-tablet supply lists near $27 on average (GoodRx, September 2026) but drops to roughly $7 to $19 with a free coupon. The extended-release capsule (brand Amrix and its generics, 15 mg and 30 mg) costs several times more in 2026, often $30 to $100 or more per month, and is usually unnecessary for short courses. The FDA label directs use for up to two or three weeks, so most patients fill only one or two prescriptions per injury.
Manufacturer assistance is not part of the cyclobenzaprine story in 2026. No manufacturer runs a patient assistance program for a generic that costs under $20 per fill, and any manufacturer coupon tied to Fexmid or Amrix is a commercial-insurance copay offer that federal anti-kickback rules bar for Medicare and Medicaid enrollees. The practical savings path is a discount coupon, a pharmacy savings club, or a 90-day supply. Cyclobenzaprine is also not among the drugs selected for negotiation under the Inflation Reduction Act, so no Maximum Fair Price applies in 2026. The Medicare price protection that does apply is the $2,100 Part D annual out-of-pocket cap, which cyclobenzaprine alone will almost never reach.
Older adults deserve a specific caution in 2026. The American Geriatrics Society Beers Criteria lists cyclobenzaprine as potentially inappropriate for people 65 and older because of anticholinergic effects, sedation, and fall risk. Medicare Part D plans may respond with quantity limits, a high-risk medication alert at the pharmacy, or in some plans a prior authorization. A prescriber can document why the drug is appropriate, and the cost of the medicine itself stays low either way. Patients who want to pay cash instead of using insurance can compare coupon prices below, since cash purchases do not count toward the Part D cap.
What Cyclobenzaprine Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same cyclobenzaprine can cost many times more at a hospital than at your local pharmacy:
2026 Cyclobenzaprine Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter with discount coupon (cash, 2026) | $7 - $19 / 30 tablets (10 mg) | Lowest prices at Walmart and Costco in 2026. Extended-release capsules cost more. |
| Pharmacy counter, no coupon (list price, 2026) | About $27 / 30 tablets (average) | Average retail price per GoodRx, September 2026. Varies by ZIP code. |
| Medicare Part D (2026) | $0 - $10 / month typical copay | Usually Tier 1 or 2 generic. Counts toward the $2,100 annual out-of-pocket cap in 2026. |
| Commercial insurance (2026) | $0 - $15 / fill | Preferred generic tier copay in most plans. Deductible plans may charge the full negotiated price of about $10 to $20 in 2026. |
| State Medicaid (2026) | $0 - $4 / fill | Nominal copay for preferred generics; varies by state and some groups pay nothing. |
| Inpatient hospital charge (2026) | $10 - $60 / tablet | Chargemaster markup on a drug that costs pennies per tablet to acquire. |
Cyclobenzaprine cost by coverage type (2026). Ranges reflect published coupon listings and typical plan copays; your price depends on plan, ZIP code, and strength.
Source: GoodRx, RxSaver, SaveHealth coupon listings (September 2026); CMS Part D 2026 parameters; CMS Hospital Price Transparency files
Why Hospitals Charge So Much
Hospitals bill oral medications at chargemaster rates that bundle drug acquisition with pharmacy dispensing, nursing administration, storage, and overhead. Cyclobenzaprine costs a hospital pennies per tablet to acquire, yet an itemized inpatient bill can show $10 to $60 per tablet in 2026. That 100x or larger markup is legal in most states, but it is also a common target when patients request an itemized bill and dispute individual medication lines. A muscle relaxant given for a back injury during an emergency department visit or observation stay is a typical example.
Cyclobenzaprine has no Medicare Part B average sales price and no J-code because it is a self-administered oral drug covered under Medicare Part D. Without a federal benchmark, the best dispute tool is comparison: the 2026 coupon price of roughly $0.25 to $0.65 per tablet, the Part D plan copay, and state Medicaid reimbursement. Patients who paid a hospital bill out of pocket can compare each line with these figures, ask the billing office for the self-pay or charity-care rate, and use the Medical Bill Analyzer to flag lines that run 20 times or more above retail.
Patient Assistance Programs
No manufacturer patient assistance program exists for generic cyclobenzaprine in 2026 because the drug costs about $7 to $19 per fill with a coupon. For someone with no insurance, the lowest-cost route is a discount coupon or store club price, not a foundation program. Income-based help that does apply comes from Medicare Extra Help (the Part D Low-Income Subsidy), state Medicaid, and NeedyMeds listings for local clinic programs.
Patient assistance programs for Cyclobenzaprine| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Medicare Extra Help (Part D Low-Income Subsidy) | Lowers Part D copays for generics to a few dollars or less in 2026 | ssa.gov/medicare/part-d-extra-help |
| NeedyMeds | Free directory of discount cards and clinic programs, 2026 | needymeds.org |
| Walmart, Costco, Kroger discount programs | Store club and generic-list prices from about $10 to $15 per fill in 2026 | Ask the pharmacy counter or visit goodrx.com |
Federal anti-kickback statute (42 U.S.C. § 1320a-7b) bars any manufacturer coupon or copay card from being used by Medicare, Medicaid, TRICARE, or VA beneficiaries. Manufacturer coupons for Fexmid or Amrix, where they exist, are for commercially insured patients only. Medicare and Medicaid enrollees should use plan coverage, Extra Help, or an income-based program instead.
Source: https://www.medicare.gov/basics/costs/help/drug-costs
Medicare Part D
Cyclobenzaprine is covered by nearly every Medicare Part D plan in 2026, almost always on a preferred generic formulary tier (Tier 1 or Tier 2) with a copay of $0 to $10 per 30-day fill. No drug-specific monthly cap exists for cyclobenzaprine, unlike the $35 insulin cap. Spending on it falls under the general 2026 Part D annual out-of-pocket cap of $2,100, after which covered drugs cost $0 for the rest of the year. Because a fill costs under $20, cyclobenzaprine alone will not approach that cap. Details on the benefit are published at cms.gov and medicare.gov.
Adults 65 and older may encounter extra plan edits in 2026 because the AGS Beers Criteria flags cyclobenzaprine as potentially inappropriate. Common edits include quantity limits (often 30 to 90 tablets per month), a pharmacy alert requiring the pharmacist to confirm with the prescriber, and in a minority of plans a prior authorization. If a plan denies or tiers the drug higher, a prescriber can file a formulary exception, and the enrollee can compare plans during open enrollment from October 15 to December 7. Cash coupons remain an option, though cash purchases do not count toward the $2,100 cap and Medicare enrollees should compare the coupon price with the plan copay first.
Common Cyclobenzaprine Billing Errors
If a hospital or urgent care bill lists cyclobenzaprine, check for these errors before paying in 2026:
- Extended-release Amrix billed when immediate-release generic tablets were given
- Duplicate line for the same tablet on the same date
- Take-home supply billed at inpatient rates instead of retail
- Separate nursing administration fee added on top of the drug charge
- Wrong strength billed (10 mg tablet coded as a higher-cost product)
Frequently Asked Questions
Is there a generic for cyclobenzaprine (Flexeril)?
Yes. Cyclobenzaprine is the generic, and it is the only form most patients receive in 2026 because brand Flexeril was discontinued in the United States. FDA-approved generic tablets (5 mg, 7.5 mg, 10 mg) and extended-release capsules come from many manufacturers. There is no biosimilar because cyclobenzaprine is a small-molecule drug, not a biologic. Branded Fexmid and Amrix cost more with no added benefit for most people, so ask your pharmacy to dispense the generic.
How do I apply for a cyclobenzaprine patient assistance program?
No manufacturer patient assistance program exists for generic cyclobenzaprine in 2026. Instead: (1) compare a free GoodRx or SingleCare coupon with Walmart, Costco, and Kroger prices, which run about $7 to $19; (2) if you have Medicare, apply for Extra Help at ssa.gov/medicare/part-d-extra-help; (3) search needymeds.org for clinic programs; (4) ask for a 90-day supply. Keep proof of income and a prescription ready. Applications are commonly denied for incomplete forms or income above the limit.
Can I use a cyclobenzaprine savings card with Medicare?
No. The federal anti-kickback statute (42 U.S.C. § 1320a-7b) prohibits manufacturer coupons and copay cards for Medicare, Medicaid, TRICARE, and VA beneficiaries. Discount-card coupons like GoodRx are different: you can use one instead of insurance, but that purchase will not count toward the 2026 Part D $2,100 out-of-pocket cap. Because the plan copay is often $0 to $10, compare both prices at the counter before choosing.
What if my insurance denies coverage for cyclobenzaprine?
Ask for the denial in writing, then have your prescriber request a formulary exception or prior authorization review. Medicare Part D redeterminations must be filed within 65 days, and expedited decisions take 72 hours. Adults 65 and older sometimes face extra review because of the Beers Criteria. If appeals fail, the 2026 coupon price of about $7 to $19 is usually less than a deductible-plan copay, and methocarbamol or tizanidine are cheap generic alternatives.
Does the Inflation Reduction Act negotiated price apply to cyclobenzaprine?
No. Cyclobenzaprine is not one of the drugs selected for Medicare negotiation under the Inflation Reduction Act, so no Maximum Fair Price applies in 2026. Negotiation targets high-spend brand drugs, not cheap generics. Medicare Part D enrollees are protected by the general 2026 annual out-of-pocket cap of $2,100 instead, though cyclobenzaprine alone will not approach it.
What does cyclobenzaprine cost without insurance at the pharmacy counter in 2026?
A 30-tablet supply of 10 mg lists near $27 on average in 2026, but a free coupon brings it to roughly $7 to $19. Published prices include about $12.68 at Walmart, $13.00 at Costco, $14.53 at Kroger, $15.79 at Walgreens, and $19.09 at CVS (GoodRx and RxSaver, September 2026). Extended-release capsules cost more, often $30 to $100 or more per month.
Do I qualify for help paying for cyclobenzaprine?
There is no manufacturer program, so eligibility runs through other channels. Medicare Extra Help uses an income guide near 150% of the 2026 federal poverty level ($23,940 for one person, $32,460 for two) plus resource limits. Medicaid eligibility varies by state, with a typical copay of $0 to $4. Non-income rules include US residency and a valid prescription. Use the Medicaid income limits page and the federal poverty level page to check thresholds.
Is cyclobenzaprine the same as Flexeril, Fexmid, and Amrix?
They share the same active ingredient. Flexeril was the original brand (discontinued in the United States), Fexmid is a branded 7.5 mg tablet, and Amrix is a branded 15 mg and 30 mg extended-release capsule. Immediate-release generic 10 mg tablets are the cheapest option in 2026 at about $7 to $19 for 30, and the label supports use for only 2 to 3 weeks.
